Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | 1M | 1M | 142,000 | 421,000 |
| Cost of revenue | 935,000 | 850,000 | 61,000 | 661,000 |
| Gross profit | 552,000 | 450,000 | 81,000 | −240,000 |
| Research and development | 7M | 5M | 7M | 6M |
| Selling, general and administrative | 5M | 4M | 4M | 4M |
| Operating income | −12M | −9M | −11M | −11M |
| Net income | −11M | −31M | −11M | −10M |
| Earnings per share | −6.15 | −55.41 | −129.26 | −5.91 |
| Earnings per share, diluted | −6.15 | −55.41 | −129.26 | −5.91 |
| Weighted average shares | 2M | 554,185 | 86,243 | 2M |
| Weighted average shares, diluted | 2M | 554,185 | 86,243 | 2M |
| Metric | 18 Aug 2026 | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | 20M | 17M | 3M | 8M | 2M |
| Receivables | — | 215,000 | 495,000 | — | — |
| Metric | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Operating cash flow | −9M | −10M | −11M | −10M |
| Depreciation and amortisation | 132,000 | 148,000 | 171,000 | 150,000 |
| Share-based compensation | 1M | 398,000 | 273,000 | 505,000 |
| Capital expenditure |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| Inventory | — | 1M | 1M | 977,000 | — | — |
| Current assets | — | 22M | 20M | 5M | — | — |
| Property, plant and equipment | — | 296,000 | 312,000 | 430,000 | — | — |
| Total assets | — | 23M | 21M | 6M | — | — |
| Current liabilities | — | 2M | 3M | 3M | — | — |
| Total liabilities | — | 2M | 3M | 3M | — | — |
| Equity | — | 20M | 18M | 3M | 8M | −8M |
| Shares outstanding | — | 2M | 1M | 3M | — | — |
| Shares issued | — | 2M | 1M | 3M | — | — |
| 125,000 |
| 30,000 |
| 152,000 |
| 29,000 |
| Investing cash flow | −125,000 | −30,000 | −152,000 | −29,000 |
| Financing cash flow | 12M | 24M | 5M | 17M |